Clindamycin HCl Capsule recall: CGMP Deviations
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Why was Clindamycin HCl Capsule recalled?
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
- Product
- Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
- Recalling firm
- RemedyRePack Inc.
- Quantity
- 23 bottles/30 count- 690 capsules
- Distribution
- Within U.S - PA, VA, FL.
- Recall date
- May 14, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)